Study Objectives: International Classification of Diseases (ICD) codes are used by many quality measures to identify cohorts of patients with disease positive states. Because emergency department (ED) patients are evaluated and managed in real-time according to their chief complaint, we hypothesize that quality measures utilizing a chief complaint-based denominator may be a more accurately reflect care delivered in the ED. In this study, we sought to compare patient demographics, disposition, and outcomes using 2 unique yet overlapping denominators using medical record data from a large health care network.
Study Objectives: International Classification of Diseases (ICD) codes are used by many quality measures to identify cohorts of patients with disease positive states. Because emergency department (ED) patients are evaluated and managed in real-time according to their chief complaint, we hypothesize that quality measures utilizing a chief complaint-based denominator may be a more accurately reflect care delivered in the ED. In this study, we sought to compare patient demographics, disposition, and outcomes using 2 unique yet overlapping denominators using medical record data from a large health care network.
Methods: Using electronic medical record data between 1/1/2017 -4/13/ 2018 from 16 different emergency departments in Western Pennsylvania, we included all patients 18 years old, afebrile (temp 38 C), for whom an ECG and troponin were ordered in the ED. We excluded any patient not evaluated in an in-network outpatient office within 365 days before the index ED visit in order to allow reliable estimation of patient comorbidities in our patient cohort. We then identified ED patients with chest pain using 2 different methods. In our chief complaint cohort, patients were selected using a text string matching algorithm. In our ICD cohort, patients were selected using a predefined set of ICD-10 diagnostic codes for chest pain which matched the denominator of a quality measure currently used by the Emergency Quality Network (E-QUAL). Patient outcomes, including 30-day rates of acute myocardial infarction and mortality were determined from subsequent medical records, including office visits, and the national death index. We compared patient demographics, ED disposition, and outcomes between our 2 patient cohorts using a Pearson's Chi-square test with alpha error rate of 0.05.
Results: Of 78,619 patients meeting our initial inclusion and exclusion criteria, 22,092 patients were identified using the chief-complaint algorithm while 21,800 patients were identified using the ICD coding method. Although there was no difference in overall admission rates between the chief complaint cohort and the ICD cohort, more patients in the ICD cohort were admitted to observation status (46.7 versus 41.4, p<0.001). In terms of 30-day outcomes, there was a higher rate of acute myocardial infarction and mortality in the chief complaint cohort relative to the ICD cohort (AMI: 2.0 versus 1.1, p<0.001; mortality: 0.8 versus 0.7, p¼0.027). Similarly, there was a higher rate of diabetes mellitus and underlying coronary artery disease in the chief complaint cohort relative to the ICD cohort (diabetes: 20.6 versus 19.6, p¼0.008; coronary artery disease: 18.7 versus 16.9, p<0.001).
Conclusions: In comparison to a chief-complaint-based denominator, an ICDbased denominator may select for a lower risk ED population with a lower incidence of short-term morbidity and mortality. Study Objectives: Dyspnea is the most common presenting symptom for acute heart failure (AHF) patients. As such, dyspnea relief has been a common endpoint in AHF clinical trials. However, there is no consensus on how to best measure dyspnea and multiple grading instruments are widely used. The objective of the DYSPNEA-AHF pilot study was to compare multiple grading instruments of dyspnea severity and improvement among AHF patients presenting to the emergency department (ED). We sought to compare their level of agreement, ability to reflect dyspnea improvement, correlation with urine output and overall quality of life, and association with inhospital and 30-day outcomes.
Methods: The DYSPNEA-AHF study is a prospective observational study of patients presenting to the ED with dyspnea due to AHF. The study is enrolling ED patients presenting with dyspnea likely secondary to AHF from 2 study sites with a target sample size of 40. Exclusion criteria include inability to self-assess dyspnea using written questionnaires (in English), a history of a durable ventricular assist device or heart transplantation, or fever at time of screening. Patients are required to be enrolled within 2 hours of first ED clinician evaluation. At time of enrollment, dyspnea is assessed by patients using 3 grading instruments (5-point Likert scale, 10-cm visual analogue scale, provocative dyspnea score) and study personnel using 1 grading instrument (4-point scale). Approximately 6 hours following enrollment, dyspnea is reassessed by patients using 4 grading instruments (as above plus 7-point Likert scale) and study personnel using the 4-point scale. Vitals signs, clinical exam, medical therapy administered, and urine output will be recorded at baseline and 6-hour dyspnea assessments. Medical record review and post-discharge phone calls will be used to ascertain clinical endpoints, including ED disposition, in-hospital mortality, 30-day mortality, and 30-day ED recidivism or hospitalization, and 30-day health-related quality of life. Patient-reported and study personnel reported dyspnea instruments will undergo pairwise comparison to assess correlation for baseline dyspnea severity and dyspnea improvement. Associations between baseline dyspnea and dyspnea improvement with clinical endpoints will be evaluated and compared for all dyspnea instruments.
Results: Interim results will be available in October 2018. Conclusions: The DYSPNEA-AHF study will provide pilot data evaluating the degree of agreement between multiple commonly used dyspnea measurement instruments in AHF and the comparative ability of these instruments to correlate with common measures of decongestion, clinical outcomes, and patient quality of life. Study Objectives: A number of previous studies have demonstrated a peak incidence of STEMI or acute myocardial infarction occurring in the morning between 6AM -12PM. We hypothesized that there is no longer a morning predominance of STEMIs and acute myocardial infarctions based on the time of presentation to the emergency department.
Methods: A retrospective review of patients with acute myocardial infarctions presenting to a multiple-hospital system were retrieved from electronic medical records for the years 2013-2017. We identified cases of STEMI and acute myocardial infarction by diagnostic codes and also collected their times of arrival to the emergency department. They were categorized into 4 time periods (12AM -5:59AM, 6AM -11:59AM, 12PM -5:59PM, 6PM -11:59PM). Chi-Square test for goodness of fit was
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